top of page

About Us

Innovative Precision

At Genera Therapies, our novel gene editing and delivery technologies can provide life-long cures to patients suffering the most challenging diseases. Our current pipeline includes development of gene based therapies to potentially potentially curative treatments in oncology, hematology and infectious diseases.

Meet The Team

Dr. Kenneth O'kelly, MD

Co-Founder & CEO

Avi Cohen, MBA

Chief Financial Officer

Dr. Raju M Kucherlapati, PhD

Chief Scientific Officer

Dr. Zhinan Ting Lai, PhD

Co-Founder and Head of Research

Dr. Robert Seder, PhD

Board Member

Dr. Jamie Lane, MD

Chairman, Board Member

One Kendall Square, Cambridge, MA 02139

©2024 by G&E International, a parent company of Genera Therapies.

bottom of page